Research graph
References from A durably colonising engineered native symbiont enables sustained intestinal delivery for metabolic dysfunction and colitis. Local targets link to admitted publications; unresolved targets remain external evidence.
10.1038/s41577-024-01014-8
10.1038/s41577-024-01014-8 · External reference
10.1016/j.cell.2024.03.034
10.1016/j.cell.2024.03.034 · External reference
Developing a new class of engineered live bacterial therapeutics to treat human diseases
10.1038/s41467-020-15508-1 · 2020 · External reference
10.1016/j.cell.2022.06.050
10.1016/j.cell.2022.06.050 · External reference
10.1016/j.chom.2024.05.002
10.1016/j.chom.2024.05.002 · External reference
10.1016/j.chom.2025.05.024
10.1016/j.chom.2025.05.024 · External reference
Fecal microbiota transplantation for antibiotic resistant bacteria decolonization
10.1016/j.humic.2020.100071 · 2020 · External reference
An expanded database and analytical toolkit for identifying bacterial virulence factors and their associations with chronic diseases
10.1038/s41467-024-51864-y · 2024 · External reference
10.1016/j.tips.2022.02.002
10.1016/j.tips.2022.02.002 · External reference
Enteral nutrition promotes the remission of colitis by gut bacteria-mediated histidine biosynthesis
10.1016/j.ebiom.2023.104959 · 2024 · External reference
Encoding bacterial colonization and therapeutic modality by wrapping with an adhesive drug-loadable nanocoating
10.1016/j.mattod.2023.01.001 · 2023 · External reference
10.1016/j.cub.2015.12.041
10.1016/j.cub.2015.12.041 · External reference
10.1021/acs.jafc.3c02997
10.1021/acs.jafc.3c02997 · External reference
10.1126/science.adp5540
10.1126/science.adp5540 · External reference
10.1264/jsme2.me16079
10.1264/jsme2.me16079 · External reference
10.1002/mlf2.12101
10.1002/mlf2.12101 · External reference
Dietary Selection Pressures and Their Impact on the Gut Microbiome
10.1016/j.jcmgh.2021.07.009 · 2022 · External reference
10.1038/nrmicro3552
10.1038/nrmicro3552 · External reference
10.1128/microbiolspec.mbp-0006-2014
10.1128/microbiolspec.mbp-0006-2014 · External reference
10.1172/jci44632
10.1172/jci44632 · External reference
Characterizing the Pathogenic Potential of Crohn’s Disease-Associated Adherent-Invasive Escherichia coli
10.1128/ecosalplus.esp-0018-2022 · 2023 · External reference
10.1099/mgen.0.000577
10.1099/mgen.0.000577 · External reference
10.1016/j.chom.2024.11.012
10.1016/j.chom.2024.11.012 · External reference
10.1038/s41586-024-08135-z
10.1038/s41586-024-08135-z · External reference
Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster
10.1371/journal.pone.0280499 · 2023 · External reference
10.1111/j.1365-2958.2010.07317.x
10.1111/j.1365-2958.2010.07317.x · External reference
10.1038/s41580-020-00313-x
10.1038/s41580-020-00313-x · External reference
10.1016/j.cell.2026.02.007
10.1016/j.cell.2026.02.007 · External reference
The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]
10.1186/1472-6904-3-4 · 2003 · External reference
10.1021/acschembio.2c00773
10.1021/acschembio.2c00773 · External reference
10.1016/j.immuni.2013.12.007
10.1016/j.immuni.2013.12.007 · External reference
10.1038/s41467-023-43622-3
10.1038/s41467-023-43622-3 · External reference
10.1016/j.jnutbio.2016.09.007
10.1016/j.jnutbio.2016.09.007 · External reference
10.1126/science.aal3535
10.1126/science.aal3535 · External reference
10.1038/ng.221
10.1038/ng.221 · External reference
10.1038/ng.717
10.1038/ng.717 · External reference
10.1038/ajg.2011.112
10.1038/ajg.2011.112 · External reference
P584 Efficacy, safety, and tolerability of AMT-101, a gut selective oral IL-10 fusion, in the Phase 2 FILLMORE trial of patients with chronic pouchitis
10.1093/ecco-jcc/jjac190.0714 · 2023 · External reference
10.1023/a:1016107230825
10.1023/a:1016107230825 · External reference
10.1038/s41575-019-0172-4
10.1038/s41575-019-0172-4 · External reference
10.1038/nbt.4222
10.1038/nbt.4222 · External reference
10.1126/science.289.5483.1352
10.1126/science.289.5483.1352 · External reference
10.1016/j.cgh.2006.03.028
10.1016/j.cgh.2006.03.028 · External reference
10.1016/j.mimet.2011.06.009
10.1016/j.mimet.2011.06.009 · External reference
10.1053/j.gastro.2013.09.060
10.1053/j.gastro.2013.09.060 · External reference
Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
10.1016/j.mtbio.2023.100543 · 2023 · External reference
10.1002/adma.202310174
10.1002/adma.202310174 · External reference
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
10.1371/journal.pone.0001308 · 2007 · External reference
10.1002/adma.202310174
10.1002/adma.202310174 · ExternalCitation · doi-reference
10.1002/mlf2.12101
10.1002/mlf2.12101 · ExternalCitation · doi-reference
10.1016/j.cell.2022.06.050
10.1016/j.cell.2022.06.050 · ExternalCitation · doi-reference
10.1016/j.cell.2024.03.034
10.1016/j.cell.2024.03.034 · ExternalCitation · doi-reference
10.1016/j.cell.2026.02.007
10.1016/j.cell.2026.02.007 · ExternalCitation · doi-reference
10.1016/j.cgh.2006.03.028
10.1016/j.cgh.2006.03.028 · ExternalCitation · doi-reference
10.1016/j.chom.2024.05.002
10.1016/j.chom.2024.05.002 · ExternalCitation · doi-reference
10.1016/j.chom.2024.11.012
10.1016/j.chom.2024.11.012 · ExternalCitation · doi-reference
10.1016/j.chom.2025.05.024
10.1016/j.chom.2025.05.024 · ExternalCitation · doi-reference
10.1016/j.cub.2015.12.041
10.1016/j.cub.2015.12.041 · ExternalCitation · doi-reference
Enteral nutrition promotes the remission of colitis by gut bacteria-mediated histidine biosynthesis
10.1016/j.ebiom.2023.104959 · ExternalCitation · doi-reference
Fecal microbiota transplantation for antibiotic resistant bacteria decolonization
10.1016/j.humic.2020.100071 · ExternalCitation · doi-reference
10.1016/j.immuni.2013.12.007
10.1016/j.immuni.2013.12.007 · ExternalCitation · doi-reference
Dietary Selection Pressures and Their Impact on the Gut Microbiome
10.1016/j.jcmgh.2021.07.009 · ExternalCitation · doi-reference
10.1016/j.jnutbio.2016.09.007
10.1016/j.jnutbio.2016.09.007 · ExternalCitation · doi-reference
Encoding bacterial colonization and therapeutic modality by wrapping with an adhesive drug-loadable nanocoating
10.1016/j.mattod.2023.01.001 · ExternalCitation · doi-reference
10.1016/j.mimet.2011.06.009
10.1016/j.mimet.2011.06.009 · ExternalCitation · doi-reference
Advances in Escherichia coli Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies
10.1016/j.mtbio.2023.100543 · ExternalCitation · doi-reference
10.1016/j.tips.2022.02.002
10.1016/j.tips.2022.02.002 · ExternalCitation · doi-reference
10.1021/acs.jafc.3c02997
10.1021/acs.jafc.3c02997 · ExternalCitation · doi-reference
10.1021/acschembio.2c00773
10.1021/acschembio.2c00773 · ExternalCitation · doi-reference
10.1023/a:1016107230825
10.1023/a:1016107230825 · ExternalCitation · doi-reference
10.1038/ajg.2011.112
10.1038/ajg.2011.112 · ExternalCitation · doi-reference
10.1038/nbt.4222
10.1038/nbt.4222 · ExternalCitation · doi-reference
10.1038/ng.221
10.1038/ng.221 · ExternalCitation · doi-reference
10.1038/ng.717
10.1038/ng.717 · ExternalCitation · doi-reference
10.1038/nrmicro3552
10.1038/nrmicro3552 · ExternalCitation · doi-reference
Developing a new class of engineered live bacterial therapeutics to treat human diseases
10.1038/s41467-020-15508-1 · ExternalCitation · doi-reference
10.1038/s41467-023-43622-3
10.1038/s41467-023-43622-3 · ExternalCitation · doi-reference
An expanded database and analytical toolkit for identifying bacterial virulence factors and their associations with chronic diseases
10.1038/s41467-024-51864-y · ExternalCitation · doi-reference
10.1038/s41575-019-0172-4
10.1038/s41575-019-0172-4 · ExternalCitation · doi-reference
10.1038/s41577-024-01014-8
10.1038/s41577-024-01014-8 · ExternalCitation · doi-reference
10.1038/s41580-020-00313-x
10.1038/s41580-020-00313-x · ExternalCitation · doi-reference
10.1038/s41586-024-08135-z
10.1038/s41586-024-08135-z · ExternalCitation · doi-reference
10.1053/j.gastro.2013.09.060
10.1053/j.gastro.2013.09.060 · ExternalCitation · doi-reference
P584 Efficacy, safety, and tolerability of AMT-101, a gut selective oral IL-10 fusion, in the Phase 2 FILLMORE trial of patients with chronic pouchitis
10.1093/ecco-jcc/jjac190.0714 · ExternalCitation · doi-reference
10.1099/mgen.0.000577
10.1099/mgen.0.000577 · ExternalCitation · doi-reference
10.1111/j.1365-2958.2010.07317.x
10.1111/j.1365-2958.2010.07317.x · ExternalCitation · doi-reference
10.1126/science.289.5483.1352
10.1126/science.289.5483.1352 · ExternalCitation · doi-reference
10.1126/science.aal3535
10.1126/science.aal3535 · ExternalCitation · doi-reference
10.1126/science.adp5540
10.1126/science.adp5540 · ExternalCitation · doi-reference
Characterizing the Pathogenic Potential of Crohn’s Disease-Associated Adherent-Invasive Escherichia coli
10.1128/ecosalplus.esp-0018-2022 · ExternalCitation · doi-reference
10.1128/microbiolspec.mbp-0006-2014
10.1128/microbiolspec.mbp-0006-2014 · ExternalCitation · doi-reference
10.1172/jci44632
10.1172/jci44632 · ExternalCitation · doi-reference
The safety of over-the-counter niacin. A randomized placebo-controlled trial [ISRCTN18054903]
10.1186/1472-6904-3-4 · ExternalCitation · doi-reference
10.1264/jsme2.me16079
10.1264/jsme2.me16079 · ExternalCitation · doi-reference
Probiotic Escherichia coli Nissle 1917 inhibits leaky gut by enhancing mucosal integrity
10.1371/journal.pone.0001308 · ExternalCitation · doi-reference
Robust performance of a live bacterial therapeutic chassis lacking the colibactin gene cluster
10.1371/journal.pone.0280499 · ExternalCitation · doi-reference
